Targeting KRAS: fragments, tool compounds & clinical candidates

Dr. Joachim Bröker (Boehringer Ingelheim RCV GmbH & Co KG)

23.03.2026, 17:15 Uhr

Universität Innsbruck, L.EG.200, Innrain 80-82, CCB